Use of innovation technology in rheumatoid arthritis patients curation


DOI: https://dx.doi.org/10.18565/therapy.2018.7-8.70-76

G.G. Bagirova, E.V. Lygina, S.S. Yakushin, M.I. Kozminskaya

1 The Department of hospital therapy of Academician I.P. Pavlov Ryazan State Medical University of the Ministry of Healthcare of Russia, Ryazan; 2 State Budgetary Institution of the Ryazan region regional clinical cardiological dispensary, Ryazan
The purpose of the study is to evaluate the efficacy and safety of managing patients with rheumatoid arthritis (RA) while using the «Internet portal for self-monitoring of rheumatoid arthritis activity».
Material and methods. The main group included 50 females with RA diagnosis at an average age of 56.3 years (35; 76). The control group consisted of 20 patients having treatment in real clinical practice. They were comparable to the main group by their clinical and demographic parameters and the degree of disease activity at the time of inclusion in the study. Previously patients were trained according to the “Structured training program for RA patients in independent monitoring of disease activity” methodology. The patient monthly makes a self-assessment of the disease activity and transmits information to his doctor by remote way. If the course of the disease is getting worse and there is no positive dynamics, according to the patient, he is invited to the center, where this information is verified by a doctor. If, by the opinion of the patient, improvement is observed, then he does not come to visit the doctor, but continues the recommended therapy. Results. For these 12 months of observation, 50 persons were examined and received treatment recommendations. It is noted the positive dynamics of RA development: the average value of the DAS28 disease activity index at the time of inclusion and after 6 months of observation is 4,023 (2.70; 5.78) and 1.59 (0.56; 4.37) (Wilcoxon T-test = 6). 8 (16%) patients at the time of inclusion in the study had 1st degree of RA activity, 38 (76%) - 2nd degree, 4 (8%) - 3rd degree. On the 12th visit, 13 (26%) patients reached the 1st degree of RA activity, 34 (68%) patients achieved remission (DAS28 <2.6). Conclusion. Monitoring of patients through the “Internet portal of self-monitoring of rheumatoid arthritis activity” allows you to quickly identify an exacerbation of the disease and timely enhance the current therapy, which leads to a more rapid achievement of remission or decrease the disease activity.
Keywords: Internet portal, rheumatoid arthritis, self-assessment of disease activity

Literature


  • WHO. A health telematics policy in support of WHO’s Health-For-All strategy for global health development: report of the WHO group consultation on health telematics, 11–16 December, Geneva, 1997. Geneva, World Health Organization, 1998.
  • URL: http://www.expo-telecom.ru/telemedical/2012/?p=1(дата обращения: 20.02.2013).
  • https://pharmvestnik.ru/articles/tixajrevoljutsija-prnt-17-m6-890.html
  • Куделина О.В., Хлынин С.М. Медицинская информатика.Томск: СибГМУ. 2009. 83 с.
  • Федеральный закон от 29.07.2017 № 242-ФЗ.
  • https://trueconf.ru/telemedicina.html
  • Kay M., Santos J., Takane M. mHealth: New horizons for health through mobile technologies. World Health Organization. 2011; 3: 66-71.
  • Grainger R., Townsley H., White B. et al. Apps for people with rheumatoid arthritis to monitor their disease activity: A review of apps for best practice and quality. JMIR mHealth uHealth. 2017 Feb 21;5(2):e7. doi: 10.2196/mhealth.6956.
  • Tani C., Trieste L., Lorenzoni V. et al. Health information technologies n systemic lupus erythematosus: focus on patient assessment.Clin Exp Rheumatol. 2016; 34(5): 54.
  • Румянцева Д.Г., Дубинина Т.В., Эрдес Ш.Ф. Проект мобильного приложения ASpine для пациентов с ранним аксиальным спондилоартритом. Научно-практическая ревматология. 2017; 55(6): 621-627.
  • http://myhealthapps.net/app/details/365/Artrite-Reumatoide
  • http://myhealthapps.net/app/details/558/Track-React
  • http://myhealthapps.net/app/details/63/ArthritisID
  • Жукова Н.В. Объем и характер лабораторных исследований у госпитализированных по поводу ревматоидного артрита. Российский медико-биологический вестник им. академика И.П. Павлова. 2011; 616.94–053.31.
  • Зотова Л.А., Петров В.С. Нестероидные противовоспалительные препараты в современной клинической практике: фокус на безопасность. «Наука молодых». 2015; 615.276.03.
  • https://medaboutme.ru/zdorove/publikacii/stati/sovety_vracha/telemeditsina_v_rossii_iz_a_rubezhom_kratkiy_analiz/?utm_source=copypaste&utm_medium=referral&utm_campaign=copypaste
  • Verstappen S.M., Bijlsma J.W., Verkleij H. et al. Utrecht Rheumatoid Arthritis Cohort Study Group. Overview of work disability in rheumatoid Arthritis patients as observed in cross-sectional and longitudinal surveys. Arthritis Rheum. 2004; 51(3): 488–97. DOI: http://dx.doi.org/10.1002/art.20419
  • https://www.rzgmu.ru/images/upload/users/sc/%D1%81%D0%B2%D0%B8%D0%B4%D0%AF%D0%BA%D1%83%D1%88%D0%B8%D0%BD.pdf
  • Burmester G.R., Pope J.E. Novel treatment strategies in rheumatoid arthritis. Lancet. 2017; 389(10086): 2338-48. doi: 10.1016/S0140-6736(17)31491-5.
  • Nagy G., van Vollenhoven R.F. Sustained biologic-free and drugfree remission in rheumatoid arthritis, where are we now? Arthritis Res Ther. 2015; 17: 181. doi: 10.1186/
  • Einarsson J.T., Willim M., Ernestam S. et al. Prevalence of sustained remission in rheumatoid arthritis: impact of criteria sets and disease duration, a Nationwide Study in Sweden. Rheumatology (Oxford). 2018 Mar 12. doi: 10.1093/rheumatology/key054.
  • Cook M.J., Diffin J., Scire C.A. et al. Predictors and outcomes of sustained, intermittent or never achieving remission in patients with recent onset inflammatory polyarthritis: results from the Norfolk Arthritis Register. Rheumatology (Oxford).

  • About the Autors


    Gulnar G. Bagirova, a graduate student of the Department of hospital therapy of Academician I.P. Pavlov Ryazan state medical university FSBEI of Higher Education of the Ministry of Healthcare of Russia. Address: 3990026, Ryazan, 9 Vysokovoltnaya St. Tel. +79537471259. E-mail: doctor.bagirova@yandex.ru
    Elena V. Lygina, PhD, assistant of the Department of hospital therapy of Academician I.P. Pavlov Ryazan state medical university FSBEI of Higher Education of the Ministry of Healthcare of Russia. Address: 3990026, Ryazan, 9 Vysokovoltnaya St. Tel.+79105761386. E-mail: dr.lygina@gmail.com
    Sergey S. Yakushin, MD, professor, head of the Department of hospital therapy of Academician I.P. Pavlov Ryazan state medical university FSBEI of Higher Education of the Ministry of Healthcare of Russia. Address: 3990026, Ryazan, 9 Vysokovoltnaya St. Tel. +79109015639. E-mail: ssyakushin@yandex.ru
    Maria I. Kozminskaya, radiologist of Regional clinical cardiological dispensary state budgetary institution of Ryazan region Address: 390026, Ryazan, 96 Stroykova St. Tel. +79156070924. E-mail: mashakozmin@icloud.com


    Бионика Медиа